Literature DB >> 16027060

The effects of local insulin delivery on diabetic fracture healing.

Ankur Gandhi1, Heather A Beam, J Patrick O'Connor, J Russell Parsons, Sheldon S Lin.   

Abstract

Several studies have documented that diabetes impairs bone healing clinically and experimentally. Systemic insulin treatment has been shown to ameliorate impaired diabetic bone healing. However, these studies failed to distinguish between a direct and a systemic effect of insulin upon bone healing. A novel intramedullary insulin delivery system was used in the diabetic BB Wistar femur fracture model to investigate the potential direct effects of insulin on bone healing. Insulin delivery at the fracture site normalized the early (cellular proliferation and chondrogenesis) and late (mineralized tissue, cartilage content and mechanical strength) parameters of diabetic fracture healing without affecting the systemic parameters of blood glucose. These results suggest a critical role for insulin in directly mediating fracture healing and that decreased systemic insulin levels in the diabetic state lead to reduced localized insulin levels at fracture site with concomitant increases in diabetic fracture healing time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027060     DOI: 10.1016/j.bone.2005.04.039

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  47 in total

Review 1.  The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease.

Authors:  Michael Hadjiargyrou; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

Review 2.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

3.  Effects of local insulin delivery on subperiosteal angiogenesis and mineralized tissue formation during fracture healing.

Authors:  David N Paglia; Aaron Wey; Eric A Breitbart; Jonathan Faiwiszewski; Siddhant K Mehta; Loay Al-Zube; Swaroopa Vaidya; Jessica A Cottrell; Dana Graves; Joseph Benevenia; J Patrick O'Connor; Sheldon S Lin
Journal:  J Orthop Res       Date:  2012-12-13       Impact factor: 3.494

4.  Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus.

Authors:  G Y Liu; G L Cao; F M Tian; H P Song; L L Yuan; L D Geng; Z Y Zheng; L Zhang
Journal:  Osteoporos Int       Date:  2017-08-14       Impact factor: 4.507

Review 5.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

6.  Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.

Authors:  Louis S Kidder; Xinqian Chen; Andrew H Schmidt; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-07-29       Impact factor: 4.176

7.  Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients.

Authors:  Charles Henri Flouzat-Lachaniette; Clemence Heyberger; Charlie Bouthors; François Roubineau; Nathalie Chevallier; Helene Rouard; Philippe Hernigou
Journal:  Int Orthop       Date:  2015-11-17       Impact factor: 3.075

8.  Contributions of the Insulin/Insulin-Like Growth Factor-1 Axis to Diabetic Osteopathy.

Authors:  John L Fowlkes; Clay Bunn R; Kathryn M Thrailkill
Journal:  J Diabetes Metab       Date:  2011-11-25

Review 9.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

10.  Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus.

Authors:  John L Fowlkes; R Clay Bunn; Lichu Liu; Elizabeth C Wahl; Hannah N Coleman; Gael E Cockrell; Daniel S Perrien; Charles K Lumpkin; Kathryn M Thrailkill
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.